Lv2
126 积分 2025-04-26 加入
Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial
8天前
已完结
Patterns of long acting injectable antipsychotic use and associated clinical factors in schizophrenia among 15 Asian countries and region
17天前
已完结
精神障碍改良电休克治疗操作规范专家共识
19天前
已完结
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial
24天前
已完结
Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia
30天前
已完结
Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia
1个月前
已完结
Clozapine After 1 Failed Antipsychotic Drug Trial in First-Episode Psychosis
1个月前
已完结
Safety, tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers
1个月前
已完结
Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate
1个月前
已完结
A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia
2个月前
已完结
皖公网安备34019202002308
